These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31411881)

  • 1. Computer-Aided Design of Mastoparan-like Peptides Enables the Generation of Nontoxic Variants with Extended Antibacterial Properties.
    Oshiro KGN; Cândido ES; Chan LY; Torres MDT; Monges BED; Rodrigues SG; Porto WF; Ribeiro SM; Henriques ST; Lu TK; de la Fuente-Nunez C; Craik DJ; Franco OL; Cardoso MH
    J Med Chem; 2019 Sep; 62(17):8140-8151. PubMed ID: 31411881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the structure and mechanism of action of computer-designed mastoparan peptides.
    Oshiro KGN; Freitas CDP; Rezende SB; Orozco RMQ; Chan LY; Lawrence N; Lião LM; Macedo MLR; Craik DJ; Cardoso MH; Franco OL
    FEBS J; 2024 Mar; 291(5):865-883. PubMed ID: 37997610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii.
    Vila-Farrés X; López-Rojas R; Pachón-Ibáñez ME; Teixidó M; Pachón J; Vila J; Giralt E
    Eur J Med Chem; 2015 Aug; 101():34-40. PubMed ID: 26114809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico and In Vitro Structure-Activity Relationship of Mastoparan and Its Analogs.
    Rungsa P; Peigneur S; Jangpromma N; Klaynongsruang S; Tytgat J; Daduang S
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Novel Mastoparan-Chitosan Nanoconstructs Against Clinical MDR
    Hassan A; Ikram A; Raza A; Saeed S; Zafar Paracha R; Younas Z; Khadim MT
    Int J Nanomedicine; 2021; 16():3755-3773. PubMed ID: 34103914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective amino acid substitution reduces cytotoxicity of the antimicrobial peptide mastoparan.
    Irazazabal LN; Porto WF; Ribeiro SM; Casale S; Humblot V; Ladram A; Franco OL
    Biochim Biophys Acta; 2016 Nov; 1858(11):2699-2708. PubMed ID: 27423268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of synthetic all-D mastoparan M.
    Li ML; Liao RW; Qiu JW; Wang ZJ; Wu TM
    Int J Antimicrob Agents; 2000 Jan; 13(3):203-8. PubMed ID: 10724025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Activity Relationship of New Chimeric Analogs of Mastoparan from the Wasp Venom
    Ruczyński J; Parfianowicz B; Mucha P; Wiśniewska K; Piechowicz L; Rekowski P
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Computationally Designed Peptide Derived from Escherichia coli as a Potential Drug Template for Antibacterial and Antibiofilm Therapies.
    Cardoso MH; Cândido ES; Chan LY; Der Torossian Torres M; Oshiro KGN; Rezende SB; Porto WF; Lu TK; de la Fuente-Nunez C; Craik DJ; Franco OL
    ACS Infect Dis; 2018 Dec; 4(12):1727-1736. PubMed ID: 30346140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unwrapping the structural and functional features of antimicrobial peptides from wasp venoms.
    Duque HM; Dos Santos C; Brango-Vanegas J; Díaz-Martín RD; Dias SC; Franco OL
    Pharmacol Res; 2024 Feb; 200():107069. PubMed ID: 38218356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral Activities of Mastoparan-L-Derived Peptides against Human Alphaherpesvirus 1.
    Vilas Boas LCP; Buccini DF; Berlanda RLA; Santos BPO; Maximiano MR; Lião LM; Gonçalves S; Santos NC; Franco OL
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Mastoparan Peptides in the Venom of the Solitary Eumenine Wasp
    Konno K; Kazuma K; Rangel M; Stolarz-de-Oliveira J; Fontana R; Kawano M; Fuchino H; Hide I; Yasuhara T; Nakata Y
    Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30857348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.
    Chen X; Zhang L; Wu Y; Wang L; Ma C; Xi X; Bininda-Emonds ORP; Shaw C; Chen T; Zhou M
    Int J Biol Sci; 2018; 14(6):599-607. PubMed ID: 29904274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MP-V1 from the Venom of Social Wasp Vespula vulgaris Is a de Novo Type of Mastoparan that Displays Superior Antimicrobial Activities.
    Kim Y; Son M; Noh EY; Kim S; Kim C; Yeo JH; Park C; Lee KW; Bang WY
    Molecules; 2016 Apr; 21(4):512. PubMed ID: 27104500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal Activity, Toxicity, and Membranolytic Action of a Mastoparan Analog Peptide.
    Singulani JL; Galeane MC; Ramos MD; Gomes PC; Dos Santos CT; de Souza BM; Palma MS; Fusco Almeida AM; Mendes Giannini MJS
    Front Cell Infect Microbiol; 2019; 9():419. PubMed ID: 31867293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Hemolytic Activity of Mastoparan Family Peptides from Wasp Venoms.
    Ye X; Zhang H; Luo X; Huang F; Sun F; Zhou L; Qin C; Ding L; Zhou H; Liu X; Chen Z
    Toxins (Basel); 2023 Sep; 15(10):. PubMed ID: 37888622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Therapeutic Properties of Mastoparan- and Sifuvirtide- Derivative Antimicrobial Peptides Using Chemical Structure-Function Relationship - in vivo and in silico Approaches.
    Avram S; Mernea M; Borcan F; Mihailescu D
    Curr Drug Deliv; 2016; 13(2):202-10. PubMed ID: 26563942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venom-derived peptide Mastoparan-1 eradicates planktonic and biofilm-embedded methicillin-resistant Staphylococcus aureus isolates.
    Memariani H; Memariani M; Pourmand MR
    Microb Pathog; 2018 Jun; 119():72-80. PubMed ID: 29626660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
    Cerovský V; Slaninová J; Fucík V; Hulacová H; Borovicková L; Jezek R; Bednárová L
    Peptides; 2008 Jun; 29(6):992-1003. PubMed ID: 18375018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
    Jones S; Howl J
    Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.